Valvular Assessment of New Generation Aortic Replacement Devices

Key facts

Sponsor

Instituto Dante Pazzanese de Cardiologia

Intervention

Dafodil prosthesis(device)

Enrollment

200 enrolled

Eligibility

18-65 years · All sexes

Timeline

2024 – 2036

Study locations (1)

• Instituto Dante Pazzanese de Cardiologia, São Paulo, São Paulo, Brazil

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Familial bicuspid aortic valve

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT06869954
  Towards a More Standardized Bicuspid Aortic Valve Repair: Rationale and Design of CONTOUR Trial - a Randomized Trial
  University Hospital Augsburg
• RECRUITINGNCT06830499
  Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China
  Xijing Hospital
• RECRUITINGNANCT06817148
  Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial
  Cedars-Sinai Medical Center
• RECRUITINGNCT06802016
  A Study of Chinese Congenital Bicuspid Aortic Valve
  Ruijin Hospital
• RECRUITINGNCT06657911
  Size Up Bicuspid with the LIra MEthod: the SUBLIME Study
  IRCCS San Raffaele
• RECRUITINGNCT06153407
  Genetic Test Based Risk Prediction of Early Calcific Aortic Valve Disease in Patients With Bicuspid Aortic Valve
  Yonsei University
• ENROLLING BY INVITATIONNCT06212050
  Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
  National University of Ireland, Galway, Ireland
• RECRUITINGNCT05739253
  Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement
  China National Center for Cardiovascular Diseases

See all trials for Familial bicuspid aortic valve →